NEW YORK, April 16, 2024 /PRNewswire/ -- The global chronic disease management market size is estimated to grow by USD 4610.51 mn from 2023 to 2027, according to Technavio. The market is estimated to grow at a CAGR of 11.09% during the forecast period.  The chronic disease management market is experiencing significant growth due to technological advancements, particularly AI.

纽约，2024年4月16日/PRNewswire/——据Technavio估计，2023年至2027年，全球慢性病管理市场规模将增长46.1051亿美元。在预测期内，市场预计将以11.09%的复合年增长率增长。由于技术进步，特别是人工智能，慢性病管理市场正在经历显着增长。

This technology enables early intervention and improved patient outcomes for conditions like diabetes, heart disease, and cancer. In February 2022, Biofourmis introduced Biofourmis Care, an AI-driven virtual care service for chronic disease patients. Keywords: Chronic diseases, Patients, Healthcare professionals, Healthcare services, Quality of life, Digital technologies, Telehealth industry, Cardiovascular diseases, Cancer, Diabetes, Musculoskeletal disorders, Geriatric population, Software systems, Care delivery, Patient devices, Smartphones, Tablets, Diagnosis, Treatment, Mobile apps, Caregivers, Clinics, Hospitals, Therapies, Screenings, Check-ups, Monitoring, Coordinating treatment..

这项技术可以对糖尿病、心脏病和癌症等疾病进行早期干预，改善患者预后。2022年2月，Biofourmis推出了Biofourmis Care，这是一种人工智能驱动的慢性病患者虚拟护理服务。关键词：慢性病、患者、医疗保健专业人员、医疗保健服务、生活质量、数字技术、远程保健行业、心血管疾病、癌症、糖尿病、肌肉骨骼疾病、老年人群、软件系统、护理服务、患者设备、智能手机、平板电脑、诊断、治疗、移动应用程序、护理人员、诊所、医院、治疗、筛查、检查、监测、协调治疗。。

Continue Reading

继续阅读

Technavio has announced its latest market research report titled Global Chronic Disease Management Market 2023-2027

Technavio宣布了其最新的市场研究报告，题为《2023-2027年全球慢性病管理市场》

To understand more about this market- Download a FREE Sample Report in minutes!

要了解这个市场的更多信息，请在几分钟内下载一份免费的示例报告！

Innovation Sparks Market Growth:

创新激发市场增长：

The Chronic Disease Management Market is experiencing significant growth due to technological advancements, particularly the adoption of digital technologies and AI. Patients suffering from chronic diseases such as cardiovascular diseases, cancer, diabetes, and musculoskeletal disorders can benefit from these innovations.

由于技术进步，特别是数字技术和人工智能的采用，慢性病管理市场正在经历显着增长。患有心血管疾病，癌症，糖尿病和肌肉骨骼疾病等慢性疾病的患者可以从这些创新中受益。

Healthcare professionals are leveraging software systems, patient devices, smartphones, and tablets to deliver high-quality medical services, including diagnosis, treatment, and monitoring. Telehealth services, a key component of the telehealth industry, enable care delivery to remote areas and improve quality of life for patients.

医疗保健专业人员正在利用软件系统、患者设备、智能手机和平板电脑提供高质量的医疗服务，包括诊断、治疗和监测。远程医疗服务是远程医疗行业的关键组成部分，能够向偏远地区提供护理，提高患者的生活质量。

AI-driven virtual care, like Biofourmis Care, coordinates treatment and facilitates early intervention for conditions like heart disease, hypertension, chronic respiratory disease, asthma, stroke, and tobacco use. Biomarkers and screenings are essential for diagnosing and managing chronic diseases. Geriatric population, who are more susceptible to chronic diseases and death, can also benefit from these advancements.

人工智能驱动的虚拟护理，如生物流护理，协调治疗并促进对心脏病，高血压，慢性呼吸系统疾病，哮喘，中风和烟草使用等疾病的早期干预。生物标志物和筛查对于诊断和管理慢性疾病至关重要。老年人群更容易患慢性病和死亡，也可以从这些进步中受益。

Digital technologies are revolutionizing care delivery, improving patient outcomes, and enhancing the overall healthcare experience.Addressing Challenges:In the Chronic Disease Management Market, software systems play a crucial role in care delivery through patient devices, such as smartphones and tablets.

数字技术正在彻底改变护理服务，改善患者预后，并增强整体医疗保健体验。应对挑战：在慢性病管理市场，软件系统在通过智能手机和平板电脑等患者设备提供护理方面发挥着至关重要的作用。

These technologies facilitate diagnosis and treatment via mobile apps, enabling real-time monitoring and coordinating therapy for various conditions, including heart disease, hypertension, chronic respiratory diseases like asthma, stroke, and tobacco use. Biomarkers are essential data points for disease management, which must be handled with utmost care due to privacy concerns.

这些技术通过移动应用程序促进诊断和治疗，从而能够实时监测和协调各种疾病的治疗，包括心脏病，高血压，哮喘，中风和烟草使用等慢性呼吸系统疾病。生物标志物是疾病管理的重要数据点，由于隐私问题，必须谨慎处理。

Regulations, such as Australia's .

法规，例如澳大利亚的法规。